Gerald said there is a lot to come in the upcoming
Post# of 30026
1. Submissions for RPDD for pediatric burns and hairy nevus.
2. Release o f early eltoprazine data in Alzheimer's aggression.
3. Release of new ESS study from Dr. Boyce.
4. GMP certification of ESS by Lonza.
5. Spin-off of diagnostics division.
6. Start ESS trials and engage DoD regarding more funding.
I think we are also awaiting CTE results for Lympro (although he didn't mention this).